Cadre (CDRE) vs Materion (MTRN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Materion (MTRN) has outperformed Cadre (CDRE) over the past year, gaining 55.3% versus a loss of 26.8%. Over five years, MTRN leads with a +108.4% price change compared with +51.0% for CDRE. Materion is the larger company by market cap ($3.81 billion vs $1.26 billion), about 3.0 times the size, while Cadre is growing revenue faster (+7.5% vs +6.0%).
On valuation, Cadre trades at a lower forward P/E (18.5x vs 20.7x for Materion). Cadre offers the higher dividend yield (1.34% vs 0.31%). Cadre converts more of its revenue into profit, with a net margin of 7.2% versus 4.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CDRE | MTRN |
|---|---|---|
| Share price | $29.45 | $182.47 |
| Market cap | $1.26B | $3.81B |
| 1-day change | -3.63% | -10.02% |
| YTD return | -27.89% | +46.77% |
| 1-year return | -26.83% | +55.33% |
| 5-year return | +51.03% | +108.37% |
| P/E ratio (TTM) | 32.36 | 37.39 |
| Forward P/E | 18.53 | 20.72 |
| EPS (TTM) | $0.91 | $4.88 |
| Dividend yield | 1.34% | 0.31% |
| Annual dividend | $0.395 | $0.57 |
| Revenue (latest FY) | $610.31M | $1.79B |
| Revenue growth (YoY) | +7.53% | +6.04% |
| Net income (latest FY) | $44.14M | $74.82M |
| Gross margin | 42.54% | 17.27% |
| Operating margin | 11.04% | 6.15% |
| Net margin | 7.23% | 4.19% |
| 52-week high | $48.76 | $324.99 |
| 52-week low | $24.07 | $116.02 |
| Distance from 52-week high | -39.60% | -43.85% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +59.02% | +44.96% |
| Average volume | 464.00K | 248.26K |
| Shares outstanding | 42.92M | 20.86M |
| Employees | 2,533 | 3,000 |
| Sector | Health Care | Industrials |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Materion is about 3.0 times larger than Cadre by market value ($3.81B vs $1.26B).
- MTRN has outperformed CDRE by 82.2 percentage points over the past year.
- Cadre offers a meaningfully higher dividend yield (1.34% vs 0.31%).
- The two companies sit in different sectors: Cadre in Health Care and Materion in Industrials.
About Cadre
CDRE stock →Cadre Holdings, Inc. manufactures and distributes safety equipment and other related products that provides protection to users in hazardous or life-threatening situations in the United States and internationally.
Health Care · Industrial Specialties · 2,533 employees
About Materion
MTRN stock →Materion Corporation, together with its subsidiaries, produces advanced engineered materials in the United States, Asia, Europe, and internationally. The company operates in four segments: Performance Materials, Electronic Materials, Precision Optics, and Other.
Industrials · Industrial Specialties · 3,000 employees
CDRE vs MTRN FAQ
Which is bigger, Cadre or Materion?
Materion (MTRN) is larger, with a market capitalization of $3.81B compared with $1.26B for Cadre (CDRE).
Which stock has performed better over the past year, CDRE or MTRN?
MTRN returned +55.33% over the past 12 months, compared with -26.83% for CDRE (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CDRE or MTRN?
CDRE has the lower trailing P/E at 32.4, versus 37.4 for MTRN. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Cadre or Materion?
Cadre has the higher yield at 1.34%, compared with 0.31% for Materion.
Are Cadre and Materion in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.